← Back to Search

Behavioural Intervention

Couple's Exercise Program for Cancer

Phase 2
Recruiting
Led By Kerri Winters-Stone
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age and older
Histologically confirmed prostate cancer or breast cancer without evidence of metastatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, months 2, month 4, and month 6
Awards & highlights

Study Summary

This trial tests a partnered exercise program that adds communication & support to couples during radiation treatment for cancer, in hopes of improving their mental & physical health.

Who is the study for?
This trial is for couples where one partner has non-metastatic breast or prostate cancer and is set to receive radiation therapy. Both must be over 18, live together, have home internet for video calls, consent to participate, and not engage in regular strength training. They can't join if they have certain medical conditions that make moderate exercise unsafe.Check my eligibility
What is being tested?
The 'Exercising Together' program is being tested to see if it helps maintain physical and mental health during cancer radiation treatment. It involves a partnered exercise routine designed to strengthen the couple's relationship while improving their fitness.See study design
What are the potential side effects?
Since this trial focuses on an exercise intervention rather than medication, side effects are minimal but may include typical exercise-related issues such as muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with prostate or breast cancer that has not spread.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, months 2, month 4, and month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, months 2, month 4, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Physical functioning
Secondary outcome measures
Changes in patient-reported symptoms
Inflammation - high sensitivity C-Reactive Protein (hsCRP)
Sexual function and satisfaction
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Exercise Together exercise program)Experimental Treatment2 Interventions
Patients and partners undergo Exercising Together exercise program during radiation therapy on study. Patients also undergo collection of blood samples throughout the trial.
Group II: Arm II (educational material)Active Control2 Interventions
Patients and partners receive educational materials specific to exercise. Patients also undergo collection of blood samples throughout the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1720

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityOTHER
981 Previous Clinical Trials
7,386,984 Total Patients Enrolled
5 Trials studying Breast Cancer
396 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,728 Previous Clinical Trials
40,965,608 Total Patients Enrolled
943 Trials studying Breast Cancer
1,543,980 Patients Enrolled for Breast Cancer
OHSU Knight Cancer InstituteLead Sponsor
231 Previous Clinical Trials
2,090,268 Total Patients Enrolled
14 Trials studying Breast Cancer
2,317 Patients Enrolled for Breast Cancer
~267 spots leftby Jun 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top